Category: Regulation & Policy

  • Ukraine Revives 1 mg Nicotine Pouch Cap as EU Tightens Tobacco Rules

    Ukraine Revives 1 mg Nicotine Pouch Cap as EU Tightens Tobacco Rules

    Ukraine’s parliament has put a controversial nicotine pouch bill back on its agenda. The proposed 1 mg-per-pouch limit would effectively wipe out the country’s existing legal pouch market, although the measure still has a long way to go before becoming law.

    Ukraine is taking another run at tightening the rules for nicotine pouches, with a bill that would restrict each pouch to just 1 mg of nicotine now back on the parliamentary agenda.

    Draft law 14110-d was formally included in the agenda for the current session of the Verkhovna Rada on September 1. The bill was originally registered in December 2025 and has the backing of Parliament’s health committee, which recommended that MPs approve it at the first reading. It has not yet received that vote, however, and the Rada’s official record still lists it as awaiting consideration.

    Some Ukrainian coverage has described the country as preparing to “ban” nicotine pouches. Nothing has been banned yet. What lawmakers are considering, though, would come fairly close in practice.

    Under the committee-backed draft, sales to minors would be prohibited along with advertising, sponsorship and promotion. Packs would also require health warnings covering at least 65% of their surface area. The most contentious provision is a maximum nicotine content of 1 mg per pouch, according to RBC-Ukraine’s coverage of the committee decision.

    That is dramatically below the strength of the products currently sold in Ukraine. RBC-Ukraine reported that no 1 mg pouches were on the Ukrainian market when the proposal was approved by the committee, meaning manufacturers would either have to develop exceptionally low-strength products for the country or withdraw from it. Calling the measure a “de facto ban” is therefore not much of a rhetorical stretch, although it remains a description of the likely commercial effect rather than the legal form of the proposal.

    Business Groups Push Back

    The 1 mg proposal has attracted opposition from the European Business Association, American Chamber of Commerce in Ukraine and Union of Ukrainian Entrepreneurs.

    In a joint appeal published by the European Business Association, the organisations argued that the limit would effectively prohibit legal pouch sales and risk pushing demand into the illicit market. They also raised concerns about lost tax revenue, the investment climate and whether parts of the proposal are consistent with European regulatory practice.

    There are concerns inside the Ukrainian government as well. Parliament’s own budget committee concluded in February that 14110-d could reduce excise and VAT receipts, although enforcement penalties could offset a portion of that loss. That finding is recorded in the official parliamentary file for the bill.

    Earlier estimates cited by RBC-Ukraine suggested that Ukraine’s Ministry of Finance believed a comparable restriction would have cost the budget around UAH 800 million in excise and VAT in 2025.

    Perhaps more significantly for a country working toward EU membership, the Rada’s European integration committee stopped short of giving the proposal an unqualified endorsement. Its official assessment found that the bill did not, as a whole, conflict with Ukraine’s international obligations in the field of European integration, but said it needed further revision and consultation with the European Commission over its additional regulatory requirements.

    That leaves lawmakers with a fairly familiar regulatory problem: there is broad agreement that nicotine pouches should not be sold to children, but considerably less agreement about whether setting a nicotine ceiling so low that the existing adult market disappears is regulation or prohibition wearing a name badge.

    Europe Is Moving Too — but Not in One Direction

    The renewed Ukrainian debate comes as the European Union is reconsidering how newer nicotine products should fit into its tobacco-control framework.

    Nicotine pouches were not a major part of the market when the current Tobacco Products Directive was written. In an evaluation published in April 2026, the European Commission said the existing framework has been overtaken in some areas by the emergence and growing use of newer products including e-cigarettes, heated tobacco products and nicotine pouches.

    National governments have meanwhile developed an assortment of different approaches to pouches, flavours, packaging and disposable vapes. That does not mean the EU has introduced a bloc-wide ban on disposable vapes or nicotine pouches.

    Instead, individual countries have increasingly used their own powers to impose stricter rules. During 2026, the European Commission approved national provisions from Bulgaria and Austria prohibiting disposable electronic cigarettes, along with restrictions on certain e-cigarettes in Ireland and Spain. Belgium and France had previously received approval for similar measures. The decisions are listed in the Commission’s Article 24(3) notification register.

    Under Article 24(3) of the Tobacco Products Directive, member states can prohibit certain categories of tobacco or related products for public-health reasons. Those measures must be notified to the European Commission, which assesses whether they are justified, necessary and proportionate and whether they create a disguised barrier to trade.

    The result is a European market that is becoming more restrictive in some areas without necessarily becoming more uniform.

    For Ukraine, that shifting landscape matters because its legislation is progressively being brought into line with the EU framework as part of the accession process. But it does not automatically provide a European justification for the 1 mg limit. Europe itself has yet to settle on a harmonised approach to nicotine pouches, and Ukraine’s own EU integration committee has already called for consultation with Brussels before additional requirements are adopted.

    The Next Fight Is Likely to Be Over the Number

    There is little indication that the basic elements of 14110-d — particularly the ban on sales to minors and tighter marketing restrictions — are going away. Ukraine’s parliamentary health committee has continued to describe stronger regulation of nicotine pouches as a public-health priority.

    The 1 mg ceiling is another matter. It is the provision that turns what would otherwise be a fairly conventional regulatory bill into something approaching a prohibition, and it is also the part most likely to keep business groups, tax authorities and lawmakers arguing as the proposal moves through Parliament.

    For now, 14110-d remains exactly that: a proposal. Its return to the parliamentary agenda makes a vote possible during the current session, but Ukraine has not yet banned nicotine pouches — and the final shape of any law could still look considerably different from the draft now on the table.

  • Canada May Allow Nicotine Pouches Back Into Convenience Stores

    Canada May Allow Nicotine Pouches Back Into Convenience Stores

    Canada’s federal government is reportedly considering changes that could allow nicotine pouches to return to convenience stores, reopening a retail channel closed by federal restrictions introduced in 2024.

    The National Post reported on September 9 that a senior government source described an openness to change following pressure from provinces and the convenience-store industry. According to follow-up coverage by Convenience Store News Canada, the source also said no decision had been made and the issue was not a government priority.

    For retailers, that leaves the prospect of a reopening without a confirmed timetable. The existing pharmacy-sales restrictions remain in place.

    Why Canada Removed Pouches From Convenience Stores

    Health Canada announced the restrictions in August 2024, citing concern that newer nicotine replacement products were attracting young people and adults who did not smoke. Its stated aim was to preserve access for adults trying to quit cigarettes while limiting recreational use.

    The measures required nicotine pouches to be kept behind pharmacy counters and sold by pharmacists or staff working under their supervision. They also restricted pouch flavors to mint and menthol, required addiction warnings and smoking-cessation labeling, and prohibited packaging and promotion that could appeal to young people.

    Established nicotine replacement formats, including gum and lozenges, retained wider retail access. Health Canada’s rationale was that those products had a longer history of appropriate use. The different treatment of pouches put a relatively new product category behind a more restrictive sales counter.

    Retailers Want Their Place in the Market Restored

    The Convenience Industry Council of Canada welcomed the reported willingness to reconsider the policy. In a statement to Convenience Store News Canada, president and CEO Anne Kothawala argued that stores already handling age-restricted products should be permitted to sell nicotine pouches.

    Kothawala also argued that excluding convenience stores redirects demand toward illegal sellers. That is the industry’s case for changing the rules, rather than an established finding that pharmacy-only sales caused the illicit market.

    What the Current Rules Actually Require

    Under Health Canada’s current place-of-sale guidance, nicotine pouches fall outside the list of nicotine replacement formats permitted for customer self-selection. Pharmacy staff must therefore intervene in the sale, including when an authorized product is purchased through a pharmacy website.

    The restriction also reaches distributors and wholesalers: products in these formats cannot be supplied to convenience stores for retail resale. Moving the stock behind an ordinary shop counter does not satisfy the existing requirement for pharmacist supervision.

    Product authorization is a separate requirement. Nicotine replacement therapies sold as natural health products must be licensed by Health Canada and display an eight-digit Natural Product Number. A change in where pouches can be sold would not, by itself, authorize unlicensed products already circulating in the market.

    A Federal Change Would Still Leave Provincial Questions

    Health Canada’s guidance on expanding retail access makes clear that provinces and territories can impose additional conditions. Even if a nicotine replacement format becomes eligible for broader sale under federal rules, a province can continue to confine it to pharmacies.

    A federal easing would therefore not necessarily produce the same retail market across Canada. Its commercial impact would depend on the wording of the change and any restrictions retained at provincial level.

    The details of any replacement rules will determine how much business can return to convenience stores, and where.